Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity
Pancreatic ductal adenocarcinoma behaves aggressively, with surgically resectable disease having the best chance of long-term survival. Recurrence after surgery and adjuvant therapy is commonly due to distant metastatic disease and is typically managed with systemic therapies, not surgery. We presen...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-02-01
|
Series: | Cancer Control |
Online Access: | https://doi.org/10.1177/1073274820904042 |
id |
doaj-af3b3d2f3ac348c987585177c4a9a577 |
---|---|
record_format |
Article |
spelling |
doaj-af3b3d2f3ac348c987585177c4a9a5772020-11-25T03:04:42ZengSAGE PublishingCancer Control1073-27482020-02-012710.1177/1073274820904042Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic EntityLuke D. Rothermel MD, MPH0Carolina Strosberg MD1Barbara A. Centeno MD2Mokenge P. Malafa MD3 Division of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Division of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USAPancreatic ductal adenocarcinoma behaves aggressively, with surgically resectable disease having the best chance of long-term survival. Recurrence after surgery and adjuvant therapy is commonly due to distant metastatic disease and is typically managed with systemic therapies, not surgery. We present a rare case of an isolated gastric metastasis due to endoscopic ultrasound-guided with fine-needle aspiration (EUS-FNA) needle tract seeding that was managed surgically. Treatment was informed by input from a mutlidisciplinary team of medical, surgical, and radiation oncologists, radiologists, and pathologists. Rising carbohydrate antigen (CA)19-9 levels suggested disease recurrence, but the tumor’s unusual location and slow growth made diagnosing the cause difficult, resulting in the late identification of the tumor. Palliative resection was performed, rending the patient with no evidence of disease followed by normalized CA19-9 levels. This case highlights the importance of multidisciplinary decision-making in detecting and treating the uncommon but significant tumor seeding with EUS-FNA biopsies in pancreatic ductal adenocarcinoma.https://doi.org/10.1177/1073274820904042 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Luke D. Rothermel MD, MPH Carolina Strosberg MD Barbara A. Centeno MD Mokenge P. Malafa MD |
spellingShingle |
Luke D. Rothermel MD, MPH Carolina Strosberg MD Barbara A. Centeno MD Mokenge P. Malafa MD Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity Cancer Control |
author_facet |
Luke D. Rothermel MD, MPH Carolina Strosberg MD Barbara A. Centeno MD Mokenge P. Malafa MD |
author_sort |
Luke D. Rothermel MD, MPH |
title |
Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity |
title_short |
Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity |
title_full |
Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity |
title_fullStr |
Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity |
title_full_unstemmed |
Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity |
title_sort |
case report of isolated gastric metastasis of pancreatic cancer from a diagnostic biopsy: management of a rare oncologic entity |
publisher |
SAGE Publishing |
series |
Cancer Control |
issn |
1073-2748 |
publishDate |
2020-02-01 |
description |
Pancreatic ductal adenocarcinoma behaves aggressively, with surgically resectable disease having the best chance of long-term survival. Recurrence after surgery and adjuvant therapy is commonly due to distant metastatic disease and is typically managed with systemic therapies, not surgery. We present a rare case of an isolated gastric metastasis due to endoscopic ultrasound-guided with fine-needle aspiration (EUS-FNA) needle tract seeding that was managed surgically. Treatment was informed by input from a mutlidisciplinary team of medical, surgical, and radiation oncologists, radiologists, and pathologists. Rising carbohydrate antigen (CA)19-9 levels suggested disease recurrence, but the tumor’s unusual location and slow growth made diagnosing the cause difficult, resulting in the late identification of the tumor. Palliative resection was performed, rending the patient with no evidence of disease followed by normalized CA19-9 levels. This case highlights the importance of multidisciplinary decision-making in detecting and treating the uncommon but significant tumor seeding with EUS-FNA biopsies in pancreatic ductal adenocarcinoma. |
url |
https://doi.org/10.1177/1073274820904042 |
work_keys_str_mv |
AT lukedrothermelmdmph casereportofisolatedgastricmetastasisofpancreaticcancerfromadiagnosticbiopsymanagementofarareoncologicentity AT carolinastrosbergmd casereportofisolatedgastricmetastasisofpancreaticcancerfromadiagnosticbiopsymanagementofarareoncologicentity AT barbaraacentenomd casereportofisolatedgastricmetastasisofpancreaticcancerfromadiagnosticbiopsymanagementofarareoncologicentity AT mokengepmalafamd casereportofisolatedgastricmetastasisofpancreaticcancerfromadiagnosticbiopsymanagementofarareoncologicentity |
_version_ |
1724680219793555456 |